These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

704 related items for PubMed ID: 2560088

  • 1. [Noninvasive diagnosis of cardiac involvement by technetium-99m-pyrophosphate (Tc-99m PYP) myocardial scintigraphy in 2 cases of familial amyloid polyneuropathy and 1 case of secondary amyloidosis].
    Takezaki M, Ishida Y, Morozumi T, Tani A, Sato H, Hori M, Kitabatake A, Kamada T, Kimura K, Kozuka T.
    Kaku Igaku; 1989 Dec; 26(12):1537-43. PubMed ID: 2560088
    [Abstract] [Full Text] [Related]

  • 2. [Cardiac involvement in systemic amyloidosis: myocardial scintigraphic evaluation].
    Hongo M, Yamada H, Okubo S, Hirayama J, Fujii T, Kusama S, Ikeda S.
    J Cardiogr; 1985 Mar; 15(1):163-80. PubMed ID: 2999267
    [Abstract] [Full Text] [Related]

  • 3. Value of positive myocardial technetium-99m-pyrophosphate scintigraphy in the noninvasive diagnosis of cardiac amyloidosis.
    Wizenberg TA, Muz J, Sohn YH, Samlowski W, Weissler AM.
    Am Heart J; 1982 Apr; 103(4 Pt 1):468-73. PubMed ID: 6278906
    [Abstract] [Full Text] [Related]

  • 4. Iodine-123 metaiodobenzylguanidine scintigraphic assessment of myocardial sympathetic innervation in patients with familial amyloid polyneuropathy.
    Tanaka M, Hongo M, Kinoshita O, Takabayashi Y, Fujii T, Yazaki Y, Isobe M, Sekiguchi M.
    J Am Coll Cardiol; 1997 Jan; 29(1):168-74. PubMed ID: 8996310
    [Abstract] [Full Text] [Related]

  • 5. Early identification of amyloid heart disease by technetium-99m-pyrophosphate scintigraphy: a study with familial amyloid polyneuropathy.
    Hongo M, Hirayama J, Fujii T, Yamada H, Okubo S, Kusama S, Ikeda S.
    Am Heart J; 1987 Mar; 113(3):654-62. PubMed ID: 3030086
    [Abstract] [Full Text] [Related]

  • 6. [Negativity of myocardial scintigraphy with technetium-pyrophosphate in a case of primary cardiac amyloidosis].
    Volpi A, Cavalli A, Maggioni AP, Inglese E, Rovelli GE, Neri R, Salvi A.
    G Ital Cardiol; 1985 Sep; 15(9):925-9. PubMed ID: 3002892
    [Abstract] [Full Text] [Related]

  • 7. [Myocardial scintigraphic studies with 123I-MIBG, 201Tl and 99mTc-PYP in patients with cardiac amyloidosis].
    Fujii T, Tanaka M, Yazaki Y, Kitabayashi H, Koizumi T, Hongo M, Sekiguchi M, Itoh A, Gomi T, Yano K.
    Kaku Igaku; 1997 Nov; 34(11):1033-9. PubMed ID: 9455044
    [Abstract] [Full Text] [Related]

  • 8. Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis.
    Falk RH, Lee VW, Rubinow A, Hood WB, Cohen AS.
    Am J Cardiol; 1983 Mar 01; 51(5):826-30. PubMed ID: 6299087
    [Abstract] [Full Text] [Related]

  • 9. [Technetium-99m-pyrophosphate single photon emission computed tomography of the heart in familial amyloid polyneuropathy: comparison with thallium-201 myocardial scintigraphy--a case report].
    Imamoto T, Morita K, Onodera S, Tanazawa S, Amoh K, Ishikawa Y, Murakami N, Kawachi H.
    Kaku Igaku; 1988 Oct 01; 25(10):1117-23. PubMed ID: 2851670
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis.
    Castano A, Haq M, Narotsky DL, Goldsmith J, Weinberg RL, Morgenstern R, Pozniakoff T, Ruberg FL, Miller EJ, Berk JL, Dispenzieri A, Grogan M, Johnson G, Bokhari S, Maurer MS.
    JAMA Cardiol; 2016 Nov 01; 1(8):880-889. PubMed ID: 27557400
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Validation of the Kumamoto criteria for prediction of 99m technetium pyrophosphate scintigraphy positivity as a strategy for diagnosis of transthyretin cardiac amyloidosis: A retrospective cohort study in Kochi.
    Ochi Y, Kubo T, Baba Y, Ueda M, Miyagawa K, Noguchi T, Hirota T, Yamasaki N, Kitaoka H.
    J Cardiol; 2021 Feb 01; 77(2):124-130. PubMed ID: 33132078
    [Abstract] [Full Text] [Related]

  • 14. Soft-tissue uptake of 99mTc-diphosphonate and 99mTc-pyrophosphate in amyloidosis.
    Janssen S, Piers DA, van Rijswijk MH, Meijer S, Mandema E.
    Eur J Nucl Med; 1990 Feb 01; 16(8-10):663-70. PubMed ID: 2166666
    [Abstract] [Full Text] [Related]

  • 15. A case of disappearing amyloid on technetium pyrophosphate scan.
    Wang A, Mahmood U, Tang X, Jain D, Pan S.
    J Nucl Cardiol; 2023 Oct 01; 30(5):1986-1991. PubMed ID: 37340232
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Wild type cardiac amyloidosis: is it time to order a nuclear technetium pyrophosphate SPECT imaging study?
    Shen CP, Vanichsarn CT, Pandey AC, Billick K, Rubenson DS, Mohan RC, Heywood JT, Srivastava AV.
    Int J Cardiovasc Imaging; 2023 Jan 01; 39(1):201-208. PubMed ID: 36598681
    [Abstract] [Full Text] [Related]

  • 20. Simultaneous Tc-99m PYP/Tl-201 dual-isotope SPECT myocardial imaging in patients with suspected cardiac amyloidosis.
    Tamarappoo B, Otaki Y, Manabe O, Hyun M, Cantu S, Arnson Y, Gransar H, Hayes SW, Friedman JD, Thomson L, Slomka P, Dey D, Vescio R, Patel J, Berman DS.
    J Nucl Cardiol; 2020 Feb 01; 27(1):28-37. PubMed ID: 31172386
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.